If you've spent two decades cycling through plans that never stuck, the idea of finally talking to a provider who actually engages can feel huge — and a little intimidating. This is a calm, step-by-step look at what a first GLP-1 consult involves, so you walk in prepared instead of nervous.

First, what "GLP-1" actually means

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. It helps signal fullness, slows how quickly the stomach empties, and supports the body's blood-sugar handling [1]. The newer medications in this category — molecules like semaglutide and tirzepatide — are designed to work along these same pathways [1][2]. Tirzepatide acts on two related receptors (GLP-1 and GIP) rather than one [2].

That's the biology. What it means for a consult is simpler: a provider is looking at your whole metabolic picture, not just a number on a scale. And to be clear up front — this article is educational and not medical advice. Whether any medication is appropriate is a decision an independent licensed provider makes with you.

Before the visit: your intake questionnaire

Most telehealth weight programs start with a written intake before you ever talk to anyone. Think of it as the conversation your rushed seven-minute physical never made room for. Expect questions about:

  • Your weight history — what you've tried, what happened, what made it hard to sustain. Decades of yo-yo dieting is information, not a failing.
  • Current health conditions — blood pressure, blood sugar, thyroid, digestion, gallbladder history, and any personal or family history of certain thyroid cancers (medullary thyroid carcinoma) or the genetic syndrome MEN 2, which are listed as important contraindications for this drug class [3].
  • Medications and allergies — including anything else you take regularly.
  • Pregnancy and breastfeeding status — this matters. These medications are generally not recommended during pregnancy, and if you're breastfeeding, that's a specific conversation to have honestly with your provider before anything is considered [3].
  • Your goals and your real life — night shifts, no sleep, three kids, aching knees. The reality of your schedule shapes what's realistic.

If you're needle-averse, this is exactly where to say so. There are both injectable and oral formulations in this space — an oral semaglutide tablet has an FDA-approved version, for example [4]. Telling the provider "I will not start with an injection" is useful information, not an inconvenience.

The path of a first GLP-1 consult
1Intake questionnaireHistory, conditions, goals, pregnancy/breastfeeding status
2Lab workOrdered fresh or recent results reviewed
3Provider consultOptions, trade-offs, and side effects discussed
4Early check-insAdjustment and contact between visits

Source: [3] FDA: Wegovy (semaglutide) Prescribing Information

The labs a provider typically reviews

A responsible weight consult usually includes lab work, either ordered fresh or reviewed from recent results. Common panels help a provider understand your baseline and rule out things that mimic or complicate weight changes. These often include:

  • A1C and/or fasting glucose — markers of blood-sugar control. The American Diabetes Association defines prediabetes as an A1C of 5.7–6.4% and diabetes at 6.5% or higher [5].
  • A lipid panel — cholesterol and triglycerides.
  • Thyroid function (TSH) — because thyroid issues can affect weight and energy.
  • Kidney and liver markers — part of a safe baseline.

These aren't pass/fail tests. They give a provider context to decide whether a given approach fits you and what to monitor over time.

How A1C is categorized
Normal ≤5.7Prediabetes ≤6.5Diabetes ≤8

% A1C · marker = Diabetes threshold

Source: [5] American Diabetes Association: Standards of Care — Classification and Diagnosis of Diabetes

What the conversation is actually like

The consult itself — by video or a structured asynchronous review — is where you get to be heard. A good provider will ask follow-up questions, explain options in plain language, and talk through trade-offs honestly. That includes side effects.

The most common side effects in this drug class are gastrointestinal: nausea, vomiting, diarrhea, and constipation, which are often most noticeable early on [3]. Providers typically discuss starting low and adjusting gradually to help the body adapt — the specifics of any schedule are the provider's role, not something to read off the internet. More serious but less common risks, like pancreatitis or gallbladder problems, are also reviewed [3]. Honest guidance beats scary anonymous stories every time.

You'll also talk about the parts medication doesn't replace: protein, movement that's kind to sore joints, and sleep. Medication, where appropriate, is a tool used alongside those — not instead of them.

Reference points from the labels and guidelines
GIMost common side effectsNausea, vomiting, diarrhea, constipation
5.7–6.4%Prediabetes A1C rangePer ADA Standards of Care
≥6.5%Diabetes A1C thresholdPer ADA Standards of Care

Source: [3] FDA: Wegovy (semaglutide) Prescribing Information, [5] American Diabetes Association: Standards of Care — Classification and Diagnosis of Diabetes

The first few weeks: what to expect (not how to dose)

If an independent provider determines a prescription is appropriate, the early weeks are about adjustment and check-ins, not dramatic milestones. In general terms, this phase tends to involve:

1. Starting and settling. Bodies adapt to this class of medication over time, which is why providers emphasize a gradual approach [3].

2. Tracking how you feel. Appetite changes, digestion, energy. Night-shift cravings and disrupted appetite are worth noting and reporting.

3. Staying in contact. Telehealth check-ins let a provider adjust the plan, address side effects, and answer questions between visits.

No responsible program promises a specific result or a number on the scale. The goal of early care is a safe, sustainable start with a provider who's paying attention.

A note on cost and compounded options

Cost is a real concern on any budget, and pricing varies widely by formulation and pharmacy. You may come across "compounded" versions of these molecules. Here's the important honesty: Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. A provider can explain how the available options differ so you can make an informed choice.

You deserve to be taken seriously

If your past experience was a pamphlet and "eat less, move more," know that a thorough consult looks nothing like that. The questions are detailed because the goal is to understand *you* — your history, your body, your life with kids and aching knees and chaotic shifts. Being plus-size or post-baby is not something to apologize for in an intake. It's simply the starting point of a real conversation.

A prescription is never guaranteed; it's a clinical decision made by an independent licensed provider. But walking in informed — knowing the questions, the labs, and the honest trade-offs — is how you go from intimidated to prepared.

Where Velri fits

Velri is a technology and coordination company — not a medical provider. We help organize the path so it's less overwhelming: coordinating lab work, connecting you with an independent, licensed provider group for your consultation, and — *if* that provider determines a prescription is appropriate — coordinating with an independent licensed pharmacy. We don't provide medical care, we don't dispense medication, and we never guarantee a prescription. Our role is to make the steps clear and the experience respectful, so the medical decisions stay where they belong: between you and your provider. This article is educational and not a substitute for individualized medical advice.